ReviewCurrent obesity reports2025

Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data.

Ioanna Α Anastasiou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.